Area of research
Cancer Research · Oncology
Research interest
Research interests include MicroRNA in disease regulation, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, and RNA modifications and cancer.
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer
Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer
Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer
Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
Coordinated regulation of WNT/β-catenin, c-Met, and Integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers
Polyol Pathway Links Glucose Metabolism to the Aggressiveness of Cancer Cells
Oncogenic Kinase–Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem–like Cells
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
Abstract 241: A novel tumor suppressor miRNA co-regulating EMT and p53-independent cell survival in breast cancer
<scp>MicroRNA</scp>‐519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour‐suppressor genes in <scp>ER</scp>+ breast cancer
Combined DNA methylation and gene expression profiling in gastrointestinal stromal tumors reveals hypomethylation of <i>SPP1</i> as an independent prognostic factor
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models
A Network-Based Method to Assess the Statistical Significance of Mild Co-Regulation Effects
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Global microRNA level regulation of EGFR‐driven cell‐cycle protein network in breast cancer
Diagnostic values of GHSR DNA methylation pattern in breast cancer
Protein phosphatase 1, regulatory subunit 15B is a survival factor for ERα‐positive breast cancer
Abstract A14: Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
Abstract 5005: Large-scale DNA methylation profiling in gastrointestinal stromal tumors (GIST) reveals epigenetic regulation of SPP1 as an independent prognostic factor